Atrium Therapeutics
RNA
#9437
Rank
โ‚ฌ0.12 B
Marketcap
7,35ย โ‚ฌ
Share price
-2.26%
Change (1 day)
-82.57%
Change (1 year)

Revenue for Atrium Therapeutics (RNA)

Revenue in 2026 (TTM): โ‚ฌ30.84 Million

According to Atrium Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ32.1 Million. In 2025 the company made a revenue of โ‚ฌ15.84 Million.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Atrium Therapeutics from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ30.84 M94.6%
2025 โ‚ฌ15.84 M